Key facts
- EsterCare’s last known valuation is $13.2M (Oct 2022).
- It has raised $4.9M; the latest was Later Stage VC ($770K) in Mar 2026.
- Notable investors include Alireza Etemad, Annika Pärson, Babak Etemad, Impact Invest Scandinavia, Josefin Landgard — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for EsterCare
- ·The full record, as it builds
Funding rounds
No funding rounds for EsterCare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EsterCare
Developer of a digital and in-person gynaecological care service platform designed to provide remote consultations and treatments for women's health needs. The company's platform offers app-based video visits, triage, prescriptions, referrals, educational content and follow-up care, enabling women patients convenient access to specialist-led gynaecological support.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2021
- Employees
- 28
- Website
- estercare.com/
- Ownership
- Privately Held (backing)
EsterCare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EsterCare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EsterCare in its N-PORT filings yet. We sweep new filings monthly.